Beyond its initial identification as a tumor-associated antigen, EpCAM has emerged as a key player in tumor development, acting as a signaling receptor and activator of the Wnt pathway, which is involved in cell proliferation, migration, and invasiveness [1,2,3]. Here, EPCAM is linked to neoplasm.